City

Birmingham (1)

Cardiff (1)

Coventry (1)

Liverpool (1)

London (1)

Madrid (1)

Majadahonda (1)

Sanchinarro (1)

Santiago De Compostela (1)

Condition

Neuroendocrine Tumours (NET) (2)

Neuroendocrine Carcinomas (NEC) (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Fundacion de investigacion HM (1)

Ipsen (1)

Collaborator

Syntax for Science, S.L (1)

Intervention

177lu-dotatate (1)

nivolumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

neuroendocrine tumours (net)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

Recruiting

Neuroendocrine Tumours (NET)
Neuroendocrine Carcinomas (NEC)

Santiago De Compostela, Galicia, Spain
+4 more

Aug 1, 2022

United Kingdom Patient Preference Study of Somatuline Autogel

Completed

Neuroendocrine Tumours (NET)

Birmingham, United Kingdom
+4 more

Jul 5, 2022